Skip to main content

Table 2 Characteristics of gastric cancer in patients with and without DM after H. pylori eradication therapy

From: Gastric cancer diagnosed after Helicobacter pylori eradication in diabetes mellitus patients

Total (n = 21) Non-DM (n = 9) DM (n = 12) p
Mean age (range), years 69.4 (56–80) 70.6 (60–78) 0.7137
Sex, n (%)    0.5533
 Female 2 (22.2 %) 1 (8.33 %)  
 Male 7 (77.8 %) 11 (91.7 %)  
Mean follow up period (range), years 4.59 (1.03–11.8) 3.95 (0.95–7.15) 0.6990
Mean endoscopy interval (range), years 1.93 (0.99–4.06) 1.62 (0.70–2.95) 0.2527
Mean body mass index (range), kg/m2 23.4 (19.5–27.5) 22.6 (19.0–30.1) 0.5534
Atrophic gastritis, n (%)    0.2030
 Mild 0 0  
 Moderate 5 (55.6 %) 3 (25.0 %)  
 Severe 4 (44.4 %) 9 (75.0 %)  
Pathology, n (%)    0.3383
 Intestinal type 8 (88.9 %) 8 (66.7 %)  
 Diffuse type 1 (11.1 %) 4 (33.3 %)  
Diameter, mm 22.1 (3–70) 25.0 (5–60) 0.7543
Depth, n (%)    0.2562
 Mucosa 6 (66.7 %) 5 (41.7 %)  
 Submucosa and deeper 3 (33.3 %) 7 (58.3 %)  
Location, n (%)    0.7332
 Upper third 3 (33.3 %) 2 (16.7 %)  
 Middle third 3 (33.3 %) 5 (41.7 %)  
 Lower third 3 (33.3 %) 5 (41.7 %)  
Treatment, n (%)    0.3869
 Endoscopic 6 (66.7 %) 5 (41.7 %)  
 Surgery 3 (33.3 %) 7 (58.3 %)  
  1. DM diabetes mellitus